Iktos, Kadmon partner to use AI for new drug design
Iktos, a company specializing in Artificial Intelligence (AI) for new drug design, today announced that it has entered into a
Read moreIktos, a company specializing in Artificial Intelligence (AI) for new drug design, today announced that it has entered into a
Read moreLundbeck South Africa, an affiliate of the global biopharmaceutical company committed to researching, developing and delivering transformative therapies for brain
Read more